semaglutide supply shortage news november 2025 Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Semaglutide Market Size & Share,

Unintentional weight loss can signal diabetes, especially type 1 or poorly controlled type 2

If the latter is the case, subscribe by pressing this button: Now, lets get to this weeks topics

Insulin Resistance HGH reduces insulin sensitivity in a dose-dependent manner, potentially increasing the risk of hyperglycemia or Type 2 diabetes in predisposed individuals

In conclusion, the SOUL trial highlights that oral semaglutide reduces cardiovascular risk in T2D patients, regardless of concurrent SGLT2i use

Underlying Health Conditions: Health conditions that contribute to weight gain, such as hormonal imbalances or other medical issues, can complicate weight maintenance

Seven additional phase 3 trial results are expected in 2026